Stockreport

Merck's Keytruda Receives Priority Review for a Key Indication [The Motley Fool]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF An approval would give the immunotherapy another big leg up on Bristol Myers Squibb's similar treatment Opdivo. [Read more]